These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8886078)

  • 1. Histopathologic characterization of hereditary benign prostatic hyperplasia.
    Doehring CB; Sanda MG; Partin AW; Sauvageot J; Juo H; Beaty TH; Epstein JI; Hill G; Walsh PC
    Urology; 1996 Oct; 48(4):650-3. PubMed ID: 8886078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?
    Berger AP; Horninger W; Bektic J; Pelzer A; Spranger R; Bartsch G; Frauscher F
    BJU Int; 2006 Sep; 98(3):587-90. PubMed ID: 16796699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.
    Salam MT; Ursin G; Skinner EC; Dessissa T; Reichardt JK
    Urol Oncol; 2005; 23(4):246-53. PubMed ID: 16018939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and biological characteristics of familial benign prostatic hyperplasia.
    Sanda MG; Doehring CB; Binkowitz B; Beaty TH; Partin AW; Hale E; Stoner E; Walsh PC
    J Urol; 1997 Mar; 157(3):876-9. PubMed ID: 9072590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases.
    Brössner C; Petritsch K; Fink K; Auprich M; Madersbacher S; Adlercreutz H; Rehak P; Petritsch P
    Urology; 2004 Oct; 64(4):707-11. PubMed ID: 15491706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New histopathological experimental model for benign prostatic hyperplasia: stromal hyperplasia in rats.
    Mori F; Oda N; Sakuragi M; Sakakibara F; Kiniwa M; Miyoshi K
    J Urol; 2009 Feb; 181(2):890-8. PubMed ID: 19095262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.
    Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
    Saudi Med J; 2004 Apr; 25(4):447-51. PubMed ID: 15083213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
    Chon JK; Borkowski A; Partin AW; Isaacs JT; Jacobs SC; Kyprianou N
    J Urol; 1999 Jun; 161(6):2002-8. PubMed ID: 10332490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salient and co-morbid features in benign prostatic hyperplasia: a histopathological study of the prostate.
    Shakya G; Malla S; Shakya KN
    Kathmandu Univ Med J (KUMJ); 2003; 1(2):104-9. PubMed ID: 16388207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study.
    Chung BH; Hong SJ; Cho JS; Seong DH
    BJU Int; 2006 Apr; 97(4):742-6. PubMed ID: 16536765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men.
    Liu CC; Huang SP; Li WM; Wang CJ; Chou YH; Li CC; Huang CH; Wu WJ
    Urology; 2007 Oct; 70(4):677-80. PubMed ID: 17991536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative morphometric study of bladder detrusor between patients with benign prostatic hyperplasia and controls.
    Inui E; Ochiai A; Naya Y; Ukimura O; Kojima M
    J Urol; 1999 Mar; 161(3):827-30. PubMed ID: 10022694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.
    Ramos CG; Carvahal GF; Mager DE; Haberer B; Catalona WJ
    J Urol; 1999 Nov; 162(5):1587-90. PubMed ID: 10524873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of prostate-specific antigen and prostate volume in Korean men with biopsy-proven benign prostatic hyperplasia.
    Lee SE; Chung JS; Han BK; Moon KH; Hwang SI; Lee HJ; Choe G; Hong SK
    Urology; 2008 Mar; 71(3):395-8. PubMed ID: 18342171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002).
    Vela-Navarrete R; Gonzalez-Enguita C; Garcia-Cardoso JV; Manzarbeitia F; Sarasa-Corral JL; Granizo JJ
    BJU Int; 2005 Nov; 96(7):1045-8. PubMed ID: 16225526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell kinetic in epithelium and stroma of benign prostatic hyperplasia.
    Claus S; Berges R; Senge T; Schulze H
    J Urol; 1997 Jul; 158(1):217-21. PubMed ID: 9186363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal nitric oxide synthase in the canine prostate: aging, sex steroid, and pathology correlations.
    Crone JK; Burnett AL; Chamness SL; Strandberg JD; Chang TS
    J Androl; 1998; 19(3):358-64. PubMed ID: 9639053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens.
    Pacelli A; Bostwick DG
    Urology; 1997 Sep; 50(3):355-9. PubMed ID: 9301697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.